Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-044663
Filing Date
2024-11-01
Accepted
2024-11-01 09:04:36
Documents
1
Period of Report
2024-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1730466270.html 4  
1 FORM 4 wk-form4_1730466270.xml 4 8760
  Complete submission text file 0001628280-24-044663.txt   10565
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Issuer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address COVENTRY HEALTH CARE, INC. 6705 ROCKLEDGE DR SUITE 900 BETHESDA MD 20817
Business Address
ACKERMAN JOEL (Reporting) CIK: 0001220630 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-11504 | Film No.: 241417243